Goldman Sachs
VXRT

Goldman Sachs’s Vaxart VXRT Stock Holding History

Goldman Sachs’s Portfolio VXRT Stock Details VXRT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-97,407
Closed -$44K – 6678
2025
Q2 		$44K Buy
97,407
+21,251
+28% +$9.25K ﹤0.01% 5928
2025
Q1 		$31K Buy
+76,156
New +$48.8K ﹤0.01% 5924
2024
Q4 		– Sell
-125,541
Closed -$107K – 6286
2024
Q3 		$107K Buy
+125,541
New +$96K ﹤0.01% 5561
2024
Q2 		– Sell
-1,498,564
Closed -$1.95M – 5952
2024
Q1 		$1.95M Buy
+1,498,564
New +$1.57M ﹤0.01% 3882
2023
Q4 		– Sell
-18,403
Closed -$13.9K – 5870
2023
Q3 		$13.9K Sell
18,403
-347,269
-95% -$264K ﹤0.01% 5383
2023
Q2 		$267K Buy
365,672
+226,270
+162% +$210K ﹤0.01% 5067
2023
Q1 		$105K Sell
139,402
-576,438
-81% -$535K ﹤0.01% 5451
2022
Q4 		$688K Sell
715,840
-654,462
-48% -$925K ﹤0.01% 4664
2022
Q3 		$2.99M Buy
1,370,302
+778,750
+132% +$2.69M ﹤0.01% 3604
2022
Q2 		$2.07M Buy
591,552
+156,874
+36% +$586K ﹤0.01% 4014
2022
Q1 		$2.19M Buy
434,678
+214,197
+97% +$1.08M ﹤0.01% 4174
2021
Q4 		$1.38M Buy
220,481
+65,646
+42% +$448K ﹤0.01% 4573
2021
Q3 		$1.23M Buy
154,835
+114,282
+282% +$941K ﹤0.01% 4588
2021
Q2 		$304K Sell
40,553
-8,658
-18% -$60.4K ﹤0.01% 5520
2021
Q1 		$298K Sell
49,211
-44,706
-48% -$344K ﹤0.01% 5436
2020
Q4 		$536K Sell
93,917
-130,087
-58% -$827K ﹤0.01% 4567
2020
Q3 		$1.49M Sell
224,004
-174,844
-44% -$1.56M ﹤0.01% 3795
2020
Q2 		$3.53M Buy
+398,848
New +$1.15M ﹤0.01% 3044
2019
Q3 		– Sell
-19,616
Closed -$13K – 5402
2019
Q2 		$13K Buy
+19,616
New +$16.4K ﹤0.01% 5072
2018
Q2 		– Sell
-10,399
Closed -$55K – 6058
2018
Q1 		$55K Buy
+10,399
New +$67.2K ﹤0.01% 5452
2016
Q4 		– Sell
-1,441
Closed -$30K – 7112
2016
Q3 		$30K Buy
1,441
+80
+6% +$1.26K ﹤0.01% 6641
2016
Q2 		$21K Sell
1,361
-3,227
-70% -$53.6K ﹤0.01% 6713
2016
Q1 		$76K Sell
4,588
-7,407
-62% -$132K ﹤0.01% 6222
2015
Q4 		$256K Buy
11,995
+8,938
+292% +$196K ﹤0.01% 5493
2015
Q3 		$67K Sell
3,057
-2,315
-43% -$56.1K ﹤0.01% 6671
2015
Q2 		$122K Sell
5,372
-96
-2% -$2.36K ﹤0.01% 6509
2015
Q1 		$138K Sell
5,468
-9,982
-65% -$275K ﹤0.01% 6267
2014
Q4 		$381K Sell
15,450
-404
-3% -$10.3K ﹤0.01% 5544
2014
Q3 		$431K Sell
15,854
-1,325
-8% -$38K ﹤0.01% 5415
2014
Q2 		$539K Buy
17,179
+10,833
+171% +$453K ﹤0.01% 5239
2014
Q1 		$427K Buy
6,346
+578
+10% +$35.7K ﹤0.01% 5421
2013
Q4 		$266K Sell
5,768
-3,568
-38% -$157K ﹤0.01% 5776
2013
Q3 		$429K Sell
9,336
-893
-9% -$38.7K ﹤0.01% 5269
2013
Q2 		$388K Buy
+10,229
New +$425K ﹤0.01% 5143

Other funds holding VXRT

Marshall Wace
Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return
XT
XTX Topco George Town, Cayman Islands $5.75B AUM 30.56% 1-Year Est. Return
HSA
HBK Sorce Advisory Erie, Pennsylvania $5.05B AUM 16.64% 1-Year Est. Return
BCMLT
Beacon Capital Management LLC (Tennessee) Franklin, Tennessee $567M AUM 16.01% 1-Year Est. Return
CFO
Custos Family Office Austin, Texas $147M AUM 17.83% 1-Year Est. Return
LCM
LVM Capital Management Portage, Michigan $1.19B AUM 41.5% 1-Year Est. Return
HWA
Heritage Wealth Advisors Richmond, Virginia $2.56B AUM 19.48% 1-Year Est. Return
Simplex Trading
Simplex Trading Chicago, Illinois $149B AUM 62.07% 1-Year Est. Return
Osaic Holdings
Osaic Holdings Scottsdale, Arizona $68.3B AUM 20.5% 1-Year Est. Return
Wealth Enhancement Advisory Services
Wealth Enhancement Advisory Services Plymouth, Minnesota $59.8B AUM 29.42% 1-Year Est. Return

Goldman Sachs's VXRT Position: Q3 2025 in Review

Goldman Sachs sold out of Vaxart (VXRT) in Q3 2025, closing a stake of 97,407 shares — an estimated $44K sold.

Goldman Sachs first reported a position in VXRT in Q2 2013 and held it in 34 quarters. The position peaked at $3.53M in Q2 2020. 17 funds tracked by Wall St. Rank hold VXRT as of Q3 2025.

  • Goldman Sachs reported no remaining Vaxart position as of Q3 2025 after selling out during the quarter.
  • Goldman Sachs sold 97,407 Vaxart shares in Q3 2025, an estimated $44K.
  • Goldman Sachs first reported a position in Vaxart in Q2 2013 and held it in 34 quarters.
  • Goldman Sachs's Vaxart position peaked at $3.53M in Q2 2020.
  • 17 funds tracked by Wall St. Rank held Vaxart as of Q3 2025.

Based on Goldman Sachs's 13F filing for Q3 2025, filed 14 Nov 2025.